NEUROPATHIX, INC.
New Form D on file · 2025-11-17 · the record
NEUROPATHIX, INC. filed a Form D with the Securities and Exchange Commission on 2025-11-17.
NEUROPATHIX, INC. filed a Form D notice of an exempt securities offering with the SEC on November 17, 2025. Its industry group is Biotechnology. It names Dean Petkanas (Executive Officer, Director) (SEC Form D, November 17, 2025).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like NEUROPATHIX, INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-11-17 · the record
Pitching, partnering or investing alongside them? See who really runs and owns NEUROPATHIX, INC.
Free to see. No signup.
More on the people and the money behind NEUROPATHIX, INC., from the filings we hold.
Biotechnology raises by companies based in Pennsylvania, filed within 90 days of this one, largest first.
Get an email when NEUROPATHIX, INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when NEUROPATHIX, INC. raises, hires or launches. No email unless you switch it on.
Watch NEUROPATHIX, INC. →Get the full cited report on NEUROPATHIX, INC.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on NEUROPATHIX, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives NEUROPATHIX, INC.'s address as 3805 Old Easton Road, Doylestown, PA 18902.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
NEUROPATHIX, INC. is a registered filer with the SEC (CIK 1615999) and has filed since 2025-11-17. 1 filing is on record, the latest on 2025-11-17.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
NEUROPATHIX, INC.'s Form D of 2025-11-17 names Dean Petkanas as its officers, directors or promoters.
Trailing twelve months. 764 filings in Biotechnology, totalled by week.
Dean Petkanas is named as Executive Officer and Director on the Form D that NEUROPATHIX, INC. filed with the SEC on 17 November 2025, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2025-11-17 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on NEUROPATHIX, INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on NEUROPATHIX, INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist NEUROPATHIX, INC.You get an alert in MentionFox the next time this company shows up.
If you're behind NEUROPATHIX, INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for NEUROPATHIX, INC.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Philadelphia
https://mentionfox.com/funding/neuropathix-inc-form-d-25000001